Pressio颅内压监测仪的体内测试
本研究为法国四家大学医院重症监护病房开展的前瞻性观察性多中心研究,纳入2018年1月1日至2020年3月31日期间需使用Pressio传感器监测颅内压的急性脑损伤患者235例,监测总时长2180天。在223个传感器(95%)拔除时测定零点漂移,中位监测时间8天(四分位距4至13天),中位零点漂移1 mmHg(四分位距1至3 mmHg),监测时长与零点漂移呈弱相关(ρ=0.141;P=0.0357),作者认为缺乏临床意义。10%传感器零点漂移>5 mmHg;4例(1.8%)出现颅内压相关血肿、无临床影响,无颅内压相关颅内感染;6例(2.6%)出现监测失败或技术故障。作者结论认为,Pressio导管在中位监测8天后零点漂移轻微,其精度与其他采用应变式技术的颅内压监测设备相当。
要点
- 急性脑损伤患者使用Pressio脑实质应变式颅内压传感器,中位监测8天(四分位距4至13天)后零点漂移中位仅1 mmHg(四分位距1至3 mmHg)。
- 10%的Pressio传感器零点漂移超过5 mmHg,床旁长期监测时需警惕个别传感器漂移偏大。
- 监测时长与零点漂移呈弱相关(ρ=0.141;P=0.0357),作者认为该相关缺乏临床意义。
- 颅内压相关血肿发生于4例(1.8%),无临床影响;无颅内压相关颅内感染;监测失败或技术故障6例(2.6%)。
- 作者结论认为Pressio导管的精度与其他采用应变式技术的颅内压监测设备相当。
适用人群与场景
- 法国四家大学医院重症监护病房中需要使用Pressio传感器测量颅内压的急性脑损伤患者,共纳入235例。
研究设计与关键结果
- 研究类型:前瞻性观察性多中心研究,法国四家大学医院重症监护病房,纳入2018年1月1日至2020年3月31日期间235例急性脑损伤患者,监测总时长2180天。
- 零点漂移在223个传感器(95%)拔除时测定;颅内压监测中位时间8天(四分位距4至13天)。
- 中位零点漂移1 mmHg(四分位距1至3 mmHg);10%的传感器零点漂移>5 mmHg。
- 监测时长与零点漂移呈弱相关(ρ=0.141;P=0.0357),作者认为缺乏临床意义。
- 4例(1.8%)出现颅内压相关血肿、无临床影响;无颅内压相关颅内感染;6例(2.6%)出现监测失败或技术故障。
证据类型、等级与局限
- 证据类型:前瞻性观察性多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,Pressio导管在中位监测8天后零点漂移轻微,其精度与其他采用应变式技术的颅内压监测设备相当。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Measuring reliable intracranial pressure (ICP) is critical for patients with acute brain injuries. The aim of this study was to evaluate zero drift of the intraparenchymal strain gauge Pressio transducer (Sophysa, Orsay, France) in clinical conditions.
METHODS: A prospective observational multicenter study was conducted in four French intensive care units of university hospitals. Patients with acute brain injuries were included if they needed ICP measurement using the Pressio transducer. The zero drift was measured at the explantation of the sensor. ICP-related adverse events were also collected.
RESULTS: Between January 1, 2018, and March 31, 2020, 235 patients were included in this study for a monitoring time of 2,180 days. The zero drift assessment was determined in 223 transducers (95%). The median duration of ICP monitoring was 8 days (interquartile range [IQR] 4 to 13 days). The median zero drift was 1 mm Hg (IQR 1 to 3 mm Hg), and a weak correlation was observed between the duration of ICP monitoring and zero drift (ρ = 0.141; P = 0.0357), which lacks clinical significance. Zero drifts higher than 5 mm Hg were found in 10% of transducers. Four patients (1.8%) had ICP-related hematomas, with no clinical impact, and none had ICP-related brain infection. Failures or technical dysfunctions of the monitoring were found in six patients (2.6%).
CONCLUSIONS: The Pressio catheter from the Sophysa system exhibited a minor zero drift after a median monitoring period of 8 days. The transducer's precision was comparable to that of other ICP devices using strain gauge technology.
参考来源
- Gergelé L, Mallard J, Magand C, et al. In vivo Testing of the Pressio Intracranial Pressure Monitor. Neurocrit Care. 2025. PMID: 40542328. doi:10.1007/s12028-025-02303-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。